💉 Sanofi's New Plant Can Change Vaccines in Days

Good Morning. This is the Investor Lookout with the daily digest.

Here’s what we got today:

  • 💉 Sanofi Opens Up New Pandemic-Ready Facility in Singapore

  • 🖥️ Samsung Names New Co-CEO Amid Chip Division Restructuring   

Sanofi Opens Up New Pandemic-Ready Facility in Singapore

Sanofi's new facility can change vaccines faster than you can get your booster shot. The pharmaceutical company is injecting $595 million into pandemic preparedness with its new Singapore facility. The Modulus plant can switch between producing different vaccines in days rather than months and manufacture up to four products simultaneously. The "evolutive vaccine facility" (EVF) can "ensure a swift and targeted response to any future health needs, including potential pandemics," the pharma giant noted.  

  • Singapore is a global biomedical hub, with 7 out of 10 largest biopharmaceutical companies having a plant in the city-state

  • It is the only such facility of the company outside France; the other one is located in Neuville-sur-Saône

Samsung Names New Co-CEO Amid Chip Division Restructuring  

Samsung Electronics is installing new management to reboot its chip business. Samsung ($KR:005930) named Jun Young-hyun as co-CEO to lead its memory chip division while appointing Han Jin-man as president of the foundry business. The company also assigned Nam Seok Woo as CTO of the foundry business in a newly created position. Samsung shares dropped 3% and have been in decline amid concerns that the company is falling behind rivals such as SK Hynix in the advanced chip-building industry.

  • Jun issued a rare apology last month after Samsung's disappointing third-quarter profit guidance

  • Citi analysts noted that the company is "maintaining stability as it has made no significant change in top management"

Market Take

Markets

French markets wracked by budget fears; Barnier warns of 'big storm.' French bonds and stocks fell on Wednesday, pushing the government's borrowing premium to its highest since the 2012 eurozone crisis. [Read]

China's industrial profits fall by 10% in October as deflation worries linger. China's industrial profits dropped by 10% in October compared to last year, another sign that Beijing's stimulus measures have yet to stabilize the economy fully. [Read]

US economy holds firm in early Q4; inflation stuck above Fed's target. Consumer spending rose 0.4% in October, showing continued economic momentum, but core PCE inflation remained elevated at 2.8%. [Read]

Business

Shares of drone maker Unusual Machines soar after Donald Trump Jr. joins advisory board. The stock of drone and drone component maker Unusual Machines ($UMAC) increased by more than 100% after the company announced that Donald Trump Jr. had joined the advisory board. [Read]

Microsoft faces wide-ranging US antitrust probe. The US Federal Trade Commission has opened a broad antitrust investigation into Microsoft ($MSFT), examining its software licensing and cloud computing businesses. [Read]

Super Micro Computer (SMCI) Terminates Its Loan Agreements With Cathay Bank And The Bank Of America. SMCI ($SMCI) terminated its loan agreements with Cathay Bank and Bank of America, voiding the deadline for furnishing its financial statements. [Read]

Investment Tip of the Day

Don't Follow The Pack. "Be fearful when others are greedy and greedy when others are fearful." — Warren Buffett

Graph of the Day

Lookout Watchlist

Name

Price

24H

YTD

Buy Rating

Talen

(TLN)

$214.05

-1.08%

+234.45%

80/100

KBR, Inc.

(KBR)

$61.18

-0.67%

+10.41%

70/100

InterDigital

(IDCC)

$196.43

+0.23%

+80.97%

75/100

Current Price

24 Hours Gain / Loss

Year to date Gain / Loss

Red-Yellow-Green

  • How Did We Do On Today’s Edition?

  • Share your feedback with us! We want to know if we can improve in any way and would love to hear your thoughts.

DISCLAIMER: None of this is financial advice. This newsletter is strictly educational and is not investment advice or a solicitation to buy or sell any assets or to make any financial decisions. Please be careful and do your own research.

Reply

or to participate.